A study explored the outcomes of treating low-risk papillary thyroid microcarcinoma (PTMC) through immediate surgery (IOP) or delayed surgery after active surveillance (DOP). DOP was an alternative to immediate surgery. Among the 516 patients undergoing surgery, DOP patients had larger tumors, more lymphatic invasion, and multifocality. However, rates of complications didn’t significantly differ. Disease progression […]

This multicenter study investigated the use of autofluorescence, specifically the Fluobeam® LX device, in thyroid surgery. Researchers aimed to determine if it helps identify and protect parathyroid glands during total thyroidectomy, potentially reducing low parathyroid hormone (PTH) levels after surgery. Among 535 patients, autofluorescence didn’t significantly lower low PTH levels in the entire group, but […]

A study exploring healthcare cost-efficiency in thyroid surgeries found that high-volume endocrine surgeons, performing over 50 cases annually, managed thyroidectomies at significantly lower costs compared to their low-volume counterparts. The cost reduction was even more pronounced when cases were categorized by relative value units, demonstrating that experienced surgeons can deliver cost-effective care without compromising quality. […]